Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (66)
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
1995 • 9,575 citations
Cancer Statistics, 2001
2001 • 3,342 citations
Systematic variation in gene expression patterns in human cancer cell lines
2000 • 2,119 citations
The Transcriptional Program in the Response of Human Fibroblasts to Serum
1999 • 1,994 citations
A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.
1996 • 1,146 citations
[12] DNA arrays for analysis of gene expression
1999 • 1,053 citations
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
1996 • 922 citations
Histology for Pathologists
1992 • 820 citations
Dual specificity phosphatases: a gene family for control of MAP kinase function
2000 • 791 citations
The Stanford Microarray Database
2001 • 540 citations
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.
1994 • 489 citations
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
1993 • 475 citations
The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells
2003 • 456 citations
The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
2003 • 332 citations
Culture of Epithelial Cells
2002 • 264 citations
Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein
1997 • 254 citations
Thioredoxin reductase
2000 • 237 citations
Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
1995 • 229 citations
Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation
1998 • 225 citations
Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.
2001 • 216 citations
Molecular Cloning and Characterization of a Novel Dual Specificity Phosphatase, MKP-5
1999 • 216 citations
1,25‐Dihydroxyvitamin D3 Regulates the Synthesis of γ‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes
1999 • 205 citations
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
2003 • 203 citations
Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21
2000 • 201 citations
Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray
2003 • 200 citations
Vitamin D and Prostate Cancer
2004 • 192 citations
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 MEDIATES 1α,25-DIHYDROXYVITAMIN D 3 GROWTH INHIBITION IN THE LNCaP PROSTATE CANCER CELL LINE THROUGH P21/WAF1
2001 • 185 citations
Gene Regulation by Vitamin D3
1998 • 185 citations
Histology for pathologists
1992 • 184 citations
Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression
2003 • 180 citations
1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.
1999 • 164 citations
Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer.
2002 • 161 citations
Regulation of Gene Expression by 1α,25-Dihydroxyvitamin D3and Its Analog EB1089 under Growth-Inhibitory Conditions in Squamous Carcinoma Cells
2001 • 149 citations
1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
2000 • 149 citations
Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays
2003 • 131 citations
1,25‐dihydroxyvitamin D3 inhibits ultraviolet B‐induced apoptosis, Jun kinase activation, and interleukin‐6 production in primary human keratinocytes
2003 • 127 citations
Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies
1998 • 124 citations
In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue
2003 • 123 citations
1α,25-Dihydroxyvitamin D3 Actions in LNCaP Human Prostate Cancer Cells Are Androgen-Dependent*
1997 • 119 citations
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
1997 • 118 citations
Induction of Androgen Receptor by 1α,25-Dihydroxyvitamin D3and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer Cells1
1999 • 116 citations
Seocalcitol (EB 1089) A Vitamin D Analogue of Anti-cancer Potential. Background, Design, Synthesis, Pre-clinical and Clinical Evaluation
2000 • 110 citations
Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells
2002 • 107 citations
Vitamin D and prostate cancer: biologic interactions and clinical potentials.
1998 • 103 citations
Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, I?,25-dihydroxycholecalciferol,all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate
1996 • 101 citations
Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein β Are Required for 1,25-Dihydroxyvitamin D3-Induced Monocytic Differentiation of HL60 Cells
2004 • 93 citations
Vitamin D
2013 • 93 citations
1α,25(OH)2Vitamin D3-Regulated Expression of the Eukaryotic Genome
2009 • 89 citations
Vitamin D3 analogs and their 24-Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects
1997 • 89 citations
Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins
1999 • 86 citations
Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes
2002 • 70 citations
Vitamin D is a prooxidant in breast cancer cells.
2001 • 64 citations
Regulation of Growth, PSA/PAP and Androgen Receptor Expression by 1α,25-Dihydroxyvitamin D3in the Androgen-Dependent LNCaP Cells
1996 • 62 citations
Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-2
2000 • 52 citations
Regulation of Gene Expression by 1 ,25-Dihydroxyvitamin D3 and Its Analog EB1089 under Growth-Inhibitory Conditions in Squamous Carcinoma Cells
2001 • 47 citations
Antiproliferative Effect of 1 ,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation
1998 • 44 citations
Induction of Androgen Receptor by 1 ,25-Dihydroxyvitamin D3 and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer Cells
1999 • 44 citations
Vitamin D and Prostate Cancer
1999 • 43 citations
1α,25(OH)2D3 Regulates Chondrocyte Matrix Vesicle Protein Kinase C (PKC) Directly via G-protein-dependent Mechanisms and Indirectly via Incorporation of PKC during Matrix Vesicle Biogenesis
2002 • 42 citations
1 ,25-Dihydroxyvitamin D3 Actions in LNCaP Human Prostate Cancer Cells Are Androgen-Dependent
1997 • 36 citations
MCF‐7/VDR: A new vitamin D resistant cell line
2001 • 35 citations
Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line
2003 • 27 citations
Simian virus 40-, but not human papillomavirus-, transformation of prostatic epithelial cells results in loss of growth-inhibition by 1,25-dihydroxyvitamin D-3
1996 • 19 citations
Progress in prostate cancer chemoprevention: modulators of promotion and progression
2001 • 19 citations
Effect of Ageing on the Expression of Protein Kinase C and Its Activation by 1,25(OH)2-Vitamin D3 in Rat Skeletal Muscle
1999 • 15 citations
Vitamin D: Biology, Action, and Clinical Implications
2010 • 13 citations